Stockscreener 앱 받기
17.38
0.80%
-0.14
시간 외 거래:
17.35
-0.03
-0.17%
전일 마감가:
$17.52
열려 있는:
$17.35
하루 거래량:
405.66K
Relative Volume:
0.94
시가총액:
$968.84M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-9.53%
1개월 성능:
-4.77%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$16.66
$17.57
1주일 범위
$16.66
$19.40
52주 변동 폭
$14.14
$24.99
Omada Health Inc Stock (OMDA) Company Profile
OMDA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OMDA
Omada Health Inc
|
17.38 | 997.40M | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
281.35 | 46.44B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
54.89 | 9.80B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
91.06 | 8.39B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
57.33 | 11.01B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
35.59 | 6.44B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omada Health Inc Stock (OMDA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-01 | 개시 | Barclays | Overweight |
| 2025-07-01 | 개시 | Canaccord Genuity | Buy |
| 2025-07-01 | 개시 | Evercore ISI | Outperform |
| 2025-07-01 | 개시 | Goldman | Buy |
| 2025-07-01 | 개시 | JP Morgan | Overweight |
| 2025-07-01 | 개시 | Morgan Stanley | Overweight |
| 2025-07-01 | 개시 | Needham | Buy |
모두보기
Omada Health Inc 주식(OMDA)의 최신 뉴스
U.S. Digital Therapeutics Market to Witness Remarkable Growth - openPR.com
Omada Health’s Strategic Partnerships and AI Leverage Drive Growth and Profitability Outlook - TipRanks
Health Coach Market is evolving rapidly Through 2025 To 2032 | Noom, Inc., HealthifyMe, Omada Health - openPR.com
Digital Therapeutics for Diabetes Market is projected to reach - openPR.com
Omada Health: Long Growth Runway Ahead - Seeking Alpha
Omada Health: A Buy Rating for a Company with Strong Distribution Partnerships and Clinical Validation - AInvest
Omada Health Sets Q2 Earnings Date: Virtual Healthcare Leader Reports August 7 - Stock Titan
Interleukin Inhibitors Market Generated Opportunities, Future Scope by 2032 | Noom, Inc., HealthifyMe, Omada Health - openPR.com
Omada Health, Inc.: A Promising Buy Amid Technical Weakness and Growth Potential - TipRanks
IPO market remains 'sluggish' despite recent San Francisco listings - The Business Journals
EQBK issues 1.73M shares, completes NBC merger & adds new director | OMDA SEC FilingForm 4 - Stock Titan
More than $16B in med-tech funding raised through 1H25 - BioWorld MedTech
The Making of Omada Health | Omada Health Co-Founder & CEO Sean Duffy - iHeart
Omada Health IPO signals healthier market, avoids ‘down-round’ trend - MSN
Omada Health (NASDAQ:OMDA) Earns Buy Rating from Analysts at Needham & Company LLC - MarketBeat
Omada Health Stock (OMDA): A Growth Story in Digital Health - Value The Markets
Omada Health stock initiated with Buy rating at Freedom Broker - Investing.com
Needham initiates coverage on Omada Health stock with Buy rating By Investing.com - Investing.com India
Omada Health initiated with a Buy at Needham - TipRanks
Omada Health initiated with an Overweight at JPMorgan - TipRanks
Omada Health initiated with an Overweight at Morgan Stanley - TipRanks
Omada Health initiated with an Overweight at Barclays - TipRanks
Don’t expect a wave of digital health IPOs quite yet - Modern Healthcare
Omada Health initiated with a Buy at Goldman Sachs - TipRanks
JPMorgan Issues Buy Rating for Omada Health, Inc. Citing Growth Potential in Underpenetrated $135 Billion Market and Strategic Partnerships - TipRanks
Omada Health: Strong Growth Prospects and Path to Profitability with Undervalued Potential - TipRanks
The long-awaited digital health IPO is back, but most late-stage healthcare startups aren't ready for it, according to bankers - Business Insider
What VCs Have Learned About Health Tech in the Public Markets - MedCity News
Omada Health prices IPO at $19 a share, raises $150M - MSN
Health Coach Market Is Booming So Rapidly 2025-2032 -Noom, Inc., HealthifyMe, Omada Health, Inc., Iora Health - openPR.com
Omada Health releases new data on its GLP-1 companion program - Yahoo Finance
New Data: Omada Health GLP-1 Program Doubles Weight Loss Success vs Standard Care - Stock Titan
Digital Therapeutics Market: Opportunities in Mental Health - openPR.com
Omada Health (NASDAQ:OMDA) Upgraded to Hold at Wall Street Zen - Defense World
Digital Musculoskeletal (MSK) Care Market Is Booming So Rapidly - openPR.com
Should You Buy Omada Health Stock After the OMDA IPO? - MSN
Omada Health Prices $150M IPO In-Line With Estimated Range - MSN
Omada & Hinge’s IPO Debuts Signal Success for Digital Health Market, Experts Say - MedCity News
Should You Buy Omada Health Stock After The OMDA IPO? - Barchart.com
Why Omada Health is resisting an AI takeover after its IPO - Business Insider
Healthcare Deals This Week: Omada, Antares, Amplify - Law360
Omada Health IPO debuts with $150m fundraise - Healthcare Brew
The "get-rich-slow business" of digital health - Axios
Smart Healthcare Is Taking Over. Here's Where the Money's Headed - Finansavisen
Omada Health’s Wei-Li Shao to target GPTs, GLP-1s following IPO - Modern Healthcare
Omada Health's Wei-Li Shao to target GPTs, GLP-1s following IPO - Modern Healthcare
Omada, Caris arrivals continue med-tech IPO hot streak - BioWorld MedTech
Virtual chronic care provider Omada Health raises $150 million in US IPO - MSN
Omada Health Completes Successful Initial Public Offering - TipRanks
Omada Wraps IPO, Raises $150M - Healthcare Innovation
Omada goes public in second recent digital health IPO - BioPharma Dive
Omada Health Inc (OMDA) 재무 분석
Omada Health Inc (OMDA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.98%
0.00%
자본화:
|
볼륨(24시간):